MENU
PYPD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

PolyPid (PYPD) Earnings Date & Reports

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology... Show more

A.I. Advisor
published Earnings

PYPD is expected to report earnings to fall 18.28% to -92 cents per share on May 07

PolyPid PYPD Stock Earnings Reports
Q1'25
Est.
$-0.92
Q4'24
Missed
by $0.22
Q3'24
Missed
by $0.22
Q2'24
Beat
by $0.05
Q1'24
Beat
by $2.78
The last earnings report on February 12 showed earnings per share of -112 cents, missing the estimate of -91 cents. With 5.38K shares outstanding, the current market capitalization sits at 28.02M.
View a ticker or compare two or three
PYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
18 Hasivim Street
Phone
+972 747195700
Employees
62
Web
https://www.polypid.com